• Kathleen Van Loon, Filip Rega, Jacques Pirenne, Katrijn Jansen, Alexander Van De Bruaene, Geertrui Dewinter, Steffen Rex, and Gert-Jan Eerdekens.
• Department of Anesthesiology, University Hospitals Leuven, Leuven, Belgium. Electronic address: vanloonkathleen@gmail.com.
• J. Cardiothorac. Vasc. Anesth. 2024 Sep 1; 38 (9): 205920692059-2069.

AbstractIn 1984, 21 years after the first liver transplantation, Thomas Starzl achieved a milestone by performing the world's first combined heart-liver transplantation. While still uncommon, the practice of combined heart-liver transplants is on the rise globally. In this review, the authors delve into the current literature on this procedure, highlighting the evolving landscape and key considerations for anesthesiologists. Over the years, there has been a remarkable increase in the number of combined heart-liver transplantations conducted worldwide. This surge is largely attributed to the growing population of adult survivors with single-ventricle physiology, palliated with a Fontan procedure, who later present with late Fontan failure and Fontan-associated liver disease. Research indicates that combined heart-liver transplantation is an effective treatment option, with reported outcomes comparable with isolated heart or liver transplants. Managing anesthesia during a combined heart-liver transplant procedure is challenging, especially in the context of underlying Fontan physiology. International experience in this field remains somewhat limited, with most techniques derived from expert opinions or experiences with single-organ heart and liver transplants. These procedures are highly complex and performed infrequently. As the number of combined heart-liver transplants continues to rise globally, there is a growing need for clear guidance on periprocedural surgical and anesthetic management. Anesthesiologists overseeing these patients must consider multiple factors, balancing various comorbidities with significant hemodynamic and metabolic shifts. An increase in (multicenter) studies focusing on specific interventions to enhance patient and organ outcomes is anticipated in the coming years.Copyright © 2024 Elsevier Inc. All rights reserved.

14 keywords...

hide…